849 related articles for article (PubMed ID: 19619785)
21. Trimodality therapy for malignant pleural mesothelioma: results from an EORTC phase II multicentre trial.
Van Schil PE; Baas P; Gaafar R; Maat AP; Van de Pol M; Hasan B; Klomp HM; Abdelrahman AM; Welch J; van Meerbeeck JP;
Eur Respir J; 2010 Dec; 36(6):1362-9. PubMed ID: 20525721
[TBL] [Abstract][Full Text] [Related]
22. [Extrapleural pneumonectomy for malignant pleural mesothelioma and primary lung cancer].
Yamamoto S; Shirakusa T
Kyobu Geka; 2004 Oct; 57(11):1005-10. PubMed ID: 15510812
[TBL] [Abstract][Full Text] [Related]
23. A phase II trial of surgical resection and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma.
Rusch VW; Rosenzweig K; Venkatraman E; Leon L; Raben A; Harrison L; Bains MS; Downey RJ; Ginsberg RJ
J Thorac Cardiovasc Surg; 2001 Oct; 122(4):788-95. PubMed ID: 11581615
[TBL] [Abstract][Full Text] [Related]
24. Extra-pleural pneumonectomy for malignant pleural mesothelioma: the risks of induction chemotherapy, right-sided procedures and prolonged operations.
Stewart DJ; Martin-Ucar AE; Edwards JG; West K; Waller DA
Eur J Cardiothorac Surg; 2005 Mar; 27(3):373-8. PubMed ID: 15740941
[TBL] [Abstract][Full Text] [Related]
25. Limited cardiotoxicity after extensive thoracic surgery and intraoperative hyperthermic intrathoracic chemotherapy with doxorubicin and cisplatin.
de Bree E; van Ruth S; Schotborgh CE; Baas P; Zoetmulder FA
Ann Surg Oncol; 2007 Oct; 14(10):3019-26. PubMed ID: 17638057
[TBL] [Abstract][Full Text] [Related]
26. Clinical and pathological features of three-year survivors of malignant pleural mesothelioma following extrapleural pneumonectomy.
Sugarbaker DJ; Wolf AS; Chirieac LR; Godleski JJ; Tilleman TR; Jaklitsch MT; Bueno R; Richards WG
Eur J Cardiothorac Surg; 2011 Aug; 40(2):298-303. PubMed ID: 21310625
[TBL] [Abstract][Full Text] [Related]
27. Trimodality therapy for malignant pleural mesothelioma.
Buduhan G; Menon S; Aye R; Louie B; Mehta V; Vallières E
Ann Thorac Surg; 2009 Sep; 88(3):870-5; discussion 876. PubMed ID: 19699914
[TBL] [Abstract][Full Text] [Related]
28. Extrapleural pneumonectomy for diffuse malignant pleural mesothelioma: techniques and complications.
Chang MY; Sugarbaker DJ
Thorac Surg Clin; 2004 Nov; 14(4):523-30. PubMed ID: 15559059
[TBL] [Abstract][Full Text] [Related]
29. Cytoreductive surgery and hyperthermic intrathoracic chemotherapy perfusion for malignant pleural tumours: perioperative management and clinical experience.
Ried M; Potzger T; Braune N; Neu R; Zausig Y; Schalke B; Diez C; Hofmann HS
Eur J Cardiothorac Surg; 2013 Apr; 43(4):801-7. PubMed ID: 22885228
[TBL] [Abstract][Full Text] [Related]
30. Malignant pleural mesothelioma. Extrapleural pneumonectomy and pleurectomy.
Allen KB; Faber LP; Warren WH
Chest Surg Clin N Am; 1994 Feb; 4(1):113-26. PubMed ID: 8055276
[TBL] [Abstract][Full Text] [Related]
31. Second surgery for recurrence of malignant pleural mesothelioma after extrapleural pneumonectomy.
Politi L; Borzellino G
Ann Thorac Surg; 2010 Jan; 89(1):207-10. PubMed ID: 20103236
[TBL] [Abstract][Full Text] [Related]
32. A feasibility study of induction pemetrexed plus cisplatin followed by extrapleural pneumonectomy and postoperative hemithoracic radiation for malignant pleural mesothelioma.
Yamanaka T; Tanaka F; Hasegawa S; Okada M; Soejima T; Kamikonya N; Fukuoka K; Nakano T
Jpn J Clin Oncol; 2009 Mar; 39(3):186-8. PubMed ID: 19131427
[TBL] [Abstract][Full Text] [Related]
33. Thoracic stop-flow perfusion in the treatment of refractory malignant pleural mesothelioma: a phase I-II evaluation/trial.
Guadagni S; Clementi M; Valenti M; Fiorentini G; Cantore M; Kanavos E; Amicucci G
In Vivo; 2006; 20(6A):715-8. PubMed ID: 17203752
[TBL] [Abstract][Full Text] [Related]
34. Right extrapleural pneumonectomy for malignant mesothelioma via median sternotomy or thoracotomy? Short- and long-term results.
Edwards JG; Martin-Ucar AE; Stewart DJ; Waller DA
Eur J Cardiothorac Surg; 2007 May; 31(5):759-64. PubMed ID: 17350854
[TBL] [Abstract][Full Text] [Related]
35. Local recurrence model of malignant pleural mesothelioma for investigation of intrapleural treatment.
Opitz I; Lardinois D; Arni S; Hillinger S; Vogt P; Odermatt B; Rousson V; Weder W
Eur J Cardiothorac Surg; 2007 May; 31(5):773-8. PubMed ID: 17350855
[TBL] [Abstract][Full Text] [Related]
36. Clinical indications and results after chest wall resection for recurrent mesothelioma.
Burt BM; Ali SO; DaSilva MC; Yeap BY; Richards WG; Baldini EH; Sugarbaker DJ
J Thorac Cardiovasc Surg; 2013 Dec; 146(6):1373-9; discussion 1379-80. PubMed ID: 24113019
[TBL] [Abstract][Full Text] [Related]
37. Phase II study of a liposome-entrapped cisplatin analog (L-NDDP) administered intrapleurally and pathologic response rates in patients with malignant pleural mesothelioma.
Lu C; Perez-Soler R; Piperdi B; Walsh GL; Swisher SG; Smythe WR; Shin HJ; Ro JY; Feng L; Truong M; Yalamanchili A; Lopez-Berestein G; Hong WK; Khokhar AR; Shin DM
J Clin Oncol; 2005 May; 23(15):3495-501. PubMed ID: 15908659
[TBL] [Abstract][Full Text] [Related]
38. Risk factors for major complications after extrapleural pneumonectomy for malignant pleural mesothelioma.
de Perrot M; McRae K; Anraku M; Karkouti K; Waddell TK; Pierre AF; Darling G; Keshavjee S; Johnston MR
Ann Thorac Surg; 2008 Apr; 85(4):1206-10. PubMed ID: 18355497
[TBL] [Abstract][Full Text] [Related]
39. Interim results of pleurectomy/decortication and intraoperative intrapleural hyperthermic cisplatin perfusion for patients with malignant pleural mesothelioma intolerable to extrapleural pneumonectomy.
Ishibashi H; Kobayashi M; Takasaki C; Okubo K
Gen Thorac Cardiovasc Surg; 2015 Jul; 63(7):395-400. PubMed ID: 25750109
[TBL] [Abstract][Full Text] [Related]
40. Pulmonary toxicity following IMRT after extrapleural pneumonectomy for malignant pleural mesothelioma.
Kristensen CA; Nøttrup TJ; Berthelsen AK; Kjaer-Kristoffersen F; Ravn J; Sørensen JB; Engelholm SA
Radiother Oncol; 2009 Jul; 92(1):96-9. PubMed ID: 19364621
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
